全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1251087-10-1 | 4-Chloro-2-cyanobenzenesulfonyl chloride | C7H3Cl2NO2S |
| 1251156-08-7 | [7-(6-Amino-3-pyridinyl)-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl][3-fluoro-2-methyl-4-(methylsulfonyl)phenyl]-methanone | C23H22FN3O4S |
| 1251716-89-8 | 2-[(6-Chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxylic acid | C9H7ClN4O2S |
| 1251732-64-5 | tert-Butyl [4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enyl]carbamate | C17H30BNO4 |
| 1251752-12-1 | N-(1,1-Dimethylethyl)-N'-[3-[[5-fluoro-4-[(2-hydroxy-1,1-dimethylethyl)amino]-2-pyrimidinyl]amino]phenyl]urea | C19H27FN6O2 |
| 1251765-07-7 | (1S,2S,3R,5S)-3-[7-Amino-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol;AR-C 133913XX | C14H22N6O4S |
| 1251830-57-5 | (6E)-1,7-Bis(4-hydroxyphenyl)-6-hepten-3-one | C19H20O3 |
| 1251903-85-1 | (alphaS)-alpha-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-4-morpholinepropanoic acid | C22H24N2O5 |
| 1251904-51-4 | (2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-7-octenoic acid | C23H25NO4 |
| 1251905-45-9 | Solifenacin Methyl Ester Impurity;Solifenacin Related Compound 13;Methyl (S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate | C17H17NO2 |
| 1251953-03-3 | 5-Bromo-2-pyridinemethanamine hydrochloride (1:2) | C6H7BrN2.2(HCl) |
| 1252003-15-8 | Tubastatin A;N-Hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide | C20H21N3O2 |
| 1252018-10-2 | (R)-4-[4-[(3-Chloro-2-hydroxypropyl)amino]phenyl]morpholin-3-one | C13H17ClN2O3 |
| 1252030-20-8 | 1-Benzyl-3-fluoro-1H-pyrrole | C11H10FN |
| 1252046-13-1 | 2-Bromo-5-iodobenzonitrile | C7H3BrIN |
| 1252555-61-5 | 4,4,9,9-Tetrakis(4-hexylphenyl)-2,7-bis(trimethylstannyl)-4,9-dihydro-s-indaceno[1,2-b:5,6-b]dithiophene;1,1'-[4,4,9,9-Tetrakis(4-hexylphenyl)-4,9-dihydro-s-indaceno[1,2-b:5,6-b']dithiophene-2,7-diyl]bis[1,1,1-trimethylstannane] | C70H90S2Sn2 |
| 1252576-14-9 | 2-[(4S)-4,5-Dihydro-4-(phenylmethyl)-2-oxazolyl]quinoline | C19H16N2O |
| 1252594-99-2 | ETP 46321;5-[2-[[4-(Methylsulfonyl)-1-piperazinyl]methyl]-8-(4-morpholinyl)imidazo[1,2-a]pyrazin-6-yl]-2-pyrimidinamine | C20H27N9O3S |
| 1252598-02-9 | Indazole-4-boronic acid, HCl | |
| 1252686-29-5 | tert-butyl (S)-(1-(4-ethoxyphenyl)-3-hydroxypropan-2-yl)carbamate;tert-butyl N-[(2S)-1-(4-ethoxyphenyl)-3-hydroxypropan-2-yl]carbamate | C16H25NO4 |
| 1252761-56-0 | (4R)-4-(3,4-Dichlorophenyl)-2-pyrrolidinone | C10H9Cl2NO |
| 1252782-43-6 | 4-Fluoro-1H-indole-5-carboxylic acid methyl ester | C10H8FNO2 |
| 1252883-90-1 | N-Methyl-N-[(3S,4S)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C20H25N5 |
| 1252914-52-5 | N-Phenyl-4-dibenzothiophenamine | C18H13NS |
| 1252934-30-7 | 3-(Bromomethyl)-1,1-difluorocyclobutane | C5H7BrF2 |
| 1253055-87-6 | 6-Cyclopropylpyridine-3-boronic acid;B-(6-Cyclopropyl-3-pyridinyl)boronic acid | C8H10BNO2 |
| 1253055-92-3 | Methyl 3-amino-4-(2,4,5-trifluorophenyl)butanoate | C11H12F3NO2 |
| 1253056-01-7 | Sitagliptin Hydroxy Amide Impurity;3-hydroxy-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one | C16H14F6N4O2 |
| 1253056-18-6 | (2E)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one | C16H12F6N4O |
| 1253282-31-3 | Fmoc-Aph(Hor)-OH;(2S)-3-[4-[[(4S)-2,6-dioxo-1,3-diazinane-4-carbonyl]amino]phenyl]-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid; 4-({[(4S)-2,6-Dioxohexahydro-4-pyrimidinyl]carbonyl}amino)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-phenylalanine | C29H26N4O7 |
| 1253291-12-1 | [4-(Difluoromethoxy)-3-[2-(2-pyridinyl)ethynyl]phenyl](5,7-dihydro-6H-pyrrolo[3,4-b]pyridin-6-yl)methanone;GRN 529 | C22H15F2N3O2 |
| 1253452-78-6 | N-[4-(2-Hydroxyethyl)phenyl]-2-[(4-nitrobenzoyl)amino]benzamide | C22H19N3O5 |
| 1253584-84-7 | 5-[2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl]-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide;NMS-E 973 | C22H22N4O7 |
| 1253654-79-3 | 4,6-Dichloro-3-methylisoxazolo[5,4-d]pyrimidine | C6H3Cl2N3O |
| 1253654-82-8 | 8-Nitro-4-oxo-4H-1-benzopyran-3-carboxaldehyde | C10H5NO5 |
| 1253730-25-4 | 3-Oxetaneethanamine | C5H11NO |
| 1253789-67-1 | tert-Butyl (5-phenylpyrrolidin-3-yl)carbamate | C15H22N2O2 |
| 1253790-61-2 | 5-Amino-1-methyl-1H-pyrazole-3-carboxylic acid ethyl ester hydrochloride | C7H11N3O2.HCl |
| 1253792-57-2 | 5,6,7,8-Tetrahydro-1,7-naphthyridine-3-carboxylic acid methyl ester hydrochloride | C10H12N2O2.HCl |
| 1253792-86-7 | (4S)-rel-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-D-proline methyl ester | C11H20N2O4 |
| 1253799-29-9 | 3-[Bis(phenylmethyl)amino]-5-fluoro-6-methyl-2-(phenylmethoxy)benzoic acid phenyl ester | C35H30FNO3 |
| 1253888-80-0 | 5,6,7,8-Tetrahydro-1,7-naphthyridine-3-carboxylic acid methyl ester | C10H12N2O2 |
| 1253912-15-0 | (2,3-Dihydro-1H-indol-6-yl)boronic acid | C8H10BNO2 |
| 1253952-02-1 | 2,4-Dimethylbenzoic acid [4-[(1S)-1-(aminomethyl)-2-(6-isoquinolinylamino)-2-oxoethyl]phenyl]methyl ester hydrochloride (1:2) | C28H27N3O3.2(HCl) |
| 1254036-66-2 | rel-N-[5-[4-[5-[[(2R,6S)-2,6-Dimethyl-4-morpholinyl]methyl]-2-oxazolyl]-1H-indazol-6-yl]-2-methoxy-3-pyridinyl]methanesulfonamide | C24H28N6O5S |
| 1254036-77-5 | 6-(1H-Indol-4-yl)-4-[5-[[4-(1-methylethyl)-1-piperazinyl]methyl]-2-oxazolyl]-1H-indazole hydrochloride (1:1) | C26H28N6O.HCl |
| 1254053-43-4 | Gilteritinib;6-Ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]-2-pyrazinecarboxamide; ASP 2215 | C29H44N8O3 |
| 1254053-84-3 | Gilteritinib fumarate;ASP 2215 hemifumarate | 2(C29H44N8O3).C4H4O4 |
| 1254115-16-6 | 4-Fluoro-4-piperidinemethanol hydrochloride | C6H12FNO.HCl |
| 1254115-23-5 | 1-(3-Oxetanyl)piperazine | C7H14N2O |